Innovative Therapeutic Approaches By Crispr/cas9 In Cancer Therapy
- Publisher's listprice GBP 155.00
-
69 982 Ft (66 650 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 8% (cc. 5 599 Ft off)
- Discounted price 64 384 Ft (61 318 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
69 982 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher World Scientific
- Date of Publication 12 March 2026
- ISBN 9789819826742
- Binding Hardback
- No. of pages472 pp pages
- Language English 695
Categories
Long description:
This book explores the groundbreaking potential of CRISPR/Cas9 gene-editing technology in revolutionizing cancer treatment. This collection of chapters delves into the application of CRISPR/Cas9 across a variety of cancers, including lung, breast, brain, gastric, pancreatic, colorectal, liver, prostate, bladder, cervical, ovarian, and bone cancers. Each chapter provides an in-depth analysis of how CRISPR/Cas9 can target and modify cancerous cells at the genetic level, offering the potential for highly personalized and precise therapies. The book also addresses the growing challenge of cancer drug resistance, detailing how CRISPR/Cas9 is being employed to study, understand, and potentially reverse resistance mechanisms, offering new hope for patients who have exhausted conventional treatment options. Furthermore, the integration of nanoparticles for efficient delivery of the CRISPR/Cas9 system is highlighted, providing a promising avenue for overcoming delivery challenges in cancer therapy.
More
